Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Sep 1976; 58(3): 565–570.
PMCID: PMC333214

Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Abstract

To determine if both phases of glucagon secretion are excessive in diabetes, arginine was admimistered intravenously as pulses and as infusions to normal subjects, insulin-dependent diabetics, and noninsulin-requiring diabetics. The acute phase of glucagon secretion, in response to arginine pulses at four different doses (submaximal to maximal alpha-cell stimulating), was indistinguishable in terms of timing, peak levels attained, and total increments comparing controls and diabetics. During the first half of the arginine infusion (500 mg/kg over 30 min) the glucagon rise in controls and diabetics was similar (P greater than 0.1), whereas during the last half of the infusion excessive glucagon levels were seen in the diabetics. No difference in the glucagon responses to arginine administered as either a pulse or an infusion was observed between the two types of diabetics. The acute phase responses of insulin to intravenous, maximal stimulating doses of glucose (20 g) and arginine (2.5 g) were measured in five insulin-independent diabetics. Although the acute insulin response to arginine was normal, there was marked attentuation of the early beta-cell response upon stimulation by glucose. From these results we conclude that although in diabetes excessive glucagon levels are observed with chronic arginine stimulation, the acute phase of glucagon secretion in response to arginine is normal. In addition, the beta-cell in noninsulin-requiring diabetics, although acutely hyporesponsive to glucose, remains normally responsive to another stimulus, arginine.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (997K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Weir GC, Knowlton SD, Martin DB. Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines. J Clin Invest. 1974 Dec;54(6):1403–1412. [PMC free article] [PubMed]
  • Iversen J. Secretion of glucagon from the isolated, perfused canine pancreas. J Clin Invest. 1971 Oct;50(10):2123–2136. [PMC free article] [PubMed]
  • Blackard WG, Nelson NC, Andrews SS. Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes. 1974 Mar;23(3):199–202. [PubMed]
  • Fajans SS, Floyd JC, Jr, Knopf RF, Pek S, Weissman P, Conn JW. Amino acids and insulin release in vivo. Isr J Med Sci. 1972 Mar;8(3):233–243. [PubMed]
  • Porte D, Jr, Pupo AA. Insulin responses to glucose: evidence for a two pool system in man. J Clin Invest. 1969 Dec;48(12):2309–2319. [PMC free article] [PubMed]
  • Cerasi E, Luft R, Efendic S. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes. 1972 Apr;21(4):224–234. [PubMed]
  • Robertson RP, Porte D., Jr The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest. 1973 Apr;52(4):870–876. [PMC free article] [PubMed]
  • Varsano-Aharon N, Echemendia E, Yalow RS, Berson SA. Early insulin responses to glucose and to tolbutamide in maturity-onset diabetes. Metabolism. 1970 Jun;19(6):409–417. [PubMed]
  • Simpson RG, Benedetti A, Grodsky GM, Karam JH, Forsham PH. Early phase of insulin release. Diabetes. 1968 Nov;17(11):684–692. [PubMed]
  • Deckert T. Insulin secretion following administration of secretin in patients with diabetes mellitus. Acta Endocrinol (Copenh) 1968 Sep;59(1):150–158. [PubMed]
  • Goodner CJ, Conway MJ, Werbach JH. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose. J Clin Invest. 1969 Oct;48(10):1878–1887. [PMC free article] [PubMed]
  • Lerner RL, Porte D., Jr Acute and steady-state insulin responses to glucose in nonobese diabetic subjects. J Clin Invest. 1972 Jul;51(7):1624–1631. [PMC free article] [PubMed]
  • Palmer JP, Ensinck JW. Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J Clin Endocrinol Metab. 1975 Sep;41(3):498–503. [PubMed]
  • Lerner RL, Porte D., Jr Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate. J Clin Endocrinol Metab. 1971 Sep;33(3):409–417. [PubMed]
  • Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W. An artificial endocrine pancreas. Diabetes. 1974 May;23(5):389–396. [PubMed]
  • Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W, Schipper H, Gander R. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974 May;23(5):397–404. [PubMed]
  • Palmer JP, Walter RM, Ensinck JW. Arginine-stimulated acute phase of insulin and glucagon secretion. I. in normal man. Diabetes. 1975 Aug;24(8):735–740. [PubMed]
  • Walter RM, Dudl RJ, Palmer JP, Ensinck JW. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man. J Clin Invest. 1974 Nov;54(5):1214–1220. [PMC free article] [PubMed]
  • Valverde I, Dobbs R, Unger RH. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs. Metabolism. 1975 Sep;24(9):1021–1028. [PubMed]
  • Felig P, Gusberg R, Hendler R, Gump FE, Kinney JM, Mulrow PJ. Concentrations of glucagon and the insulin:glucagon ratio in the portal and peripheral circulation. Proc Soc Exp Biol Med. 1974 Oct;147(1):88–90. [PubMed]
  • Frankel BJ, Gerich JE, Fanska RE, Gerritsen GC, Grodsky GM. Responses to arginine of the perfused pancreas of the genetically diabetic Chinese hamster. Diabetes. 1975 Mar;24(3):273–279. [PubMed]
  • Unger RH, Aguilar-Parada E, Müller WA, Eisentraut AM. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest. 1970 Apr;49(4):837–848. [PMC free article] [PubMed]
  • Thorell JI, Nosslin B, Sterky G. Estimation of the early insulin response to intravenous glucose injection. J Lab Clin Med. 1973 Jul;82(1):101–110. [PubMed]
  • Müller WA, Faloona GR, Aguilar-Parada E, Unger RH. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med. 1970 Jul 16;283(3):109–115. [PubMed]
  • Seltzer HS, Allen EW, Herron AL, Jr, Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest. 1967 Mar;46(3):323–335. [PMC free article] [PubMed]
  • Vinik AI, Kalk WJ, Jackson WP. A unifying hypothesis for hereditary and acquired diabetes. Lancet. 1974 Mar 23;1(7856):485–487. [PubMed]
  • Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 1973 Oct 12;182(4108):171–173. [PubMed]
  • Lund B, Schmidt A, Deckert T. Portal and cubital serum insulin during oral, portal and cubital glucose tolerance tests. Acta Med Scand. 1975 Apr;197(4):275–281. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...